JP2015529211A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529211A5
JP2015529211A5 JP2015530374A JP2015530374A JP2015529211A5 JP 2015529211 A5 JP2015529211 A5 JP 2015529211A5 JP 2015530374 A JP2015530374 A JP 2015530374A JP 2015530374 A JP2015530374 A JP 2015530374A JP 2015529211 A5 JP2015529211 A5 JP 2015529211A5
Authority
JP
Japan
Prior art keywords
fusion polypeptide
sample
analyte
skp
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015530374A
Other languages
English (en)
Japanese (ja)
Other versions
JP6285934B2 (ja
JP2015529211A (ja
Filing date
Publication date
Priority claimed from EP12006298.9A external-priority patent/EP2706115A1/en
Application filed filed Critical
Publication of JP2015529211A publication Critical patent/JP2015529211A/ja
Publication of JP2015529211A5 publication Critical patent/JP2015529211A5/ja
Application granted granted Critical
Publication of JP6285934B2 publication Critical patent/JP6285934B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015530374A 2012-09-06 2013-09-04 イムノアッセイの干渉の低減、及び安定化のためのシャペロン−シャペロン融合ポリペプチド Active JP6285934B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12006298.9 2012-09-06
EP12006298.9A EP2706115A1 (en) 2012-09-06 2012-09-06 Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays
PCT/EP2013/068269 WO2014037389A1 (en) 2012-09-06 2013-09-04 Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays

Publications (3)

Publication Number Publication Date
JP2015529211A JP2015529211A (ja) 2015-10-05
JP2015529211A5 true JP2015529211A5 (enExample) 2016-09-15
JP6285934B2 JP6285934B2 (ja) 2018-02-28

Family

ID=46963361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015530374A Active JP6285934B2 (ja) 2012-09-06 2013-09-04 イムノアッセイの干渉の低減、及び安定化のためのシャペロン−シャペロン融合ポリペプチド

Country Status (6)

Country Link
US (1) US10197559B2 (enExample)
EP (2) EP2706115A1 (enExample)
JP (1) JP6285934B2 (enExample)
CN (1) CN104583408B (enExample)
CA (1) CA2881411C (enExample)
WO (1) WO2014037389A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017153336A1 (en) * 2016-03-07 2017-09-14 F. Hoffmann-La Roche Ag Detection of anti-p53 antibodies
CN110996986B (zh) * 2017-07-27 2024-07-19 豪夫迈·罗氏有限公司 Hcv抗原的多表位融合蛋白及其用途
CA3076337A1 (en) 2017-09-19 2019-03-28 Massachusetts Institute Of Technology Compositions for chimeric antigen receptor t cell therapy and uses thereof
WO2021214248A1 (en) 2020-04-23 2021-10-28 F. Hoffmann-La Roche Ag Corona nucleocapsid antigen for use in antibody-immunoassays
EP4519285A1 (en) 2022-05-03 2025-03-12 F. Hoffmann-La Roche AG Hiv gp41 variants for immunodiagnostic assays
WO2025098623A1 (en) 2023-11-09 2025-05-15 Roche Diagnostics Gmbh Transglutaminase substrates for labeling
WO2026027625A1 (en) 2024-07-31 2026-02-05 Roche Diagnostics Gmbh Hepatitis delta virus polypeptides and detection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100702373B1 (ko) 2001-06-22 2007-04-02 에프. 호프만-라 로슈 아게 레트로바이러스 표면 당단백질을 함유하는 가용성 복합체
JP4871960B2 (ja) * 2006-01-03 2012-02-08 エフ.ホフマン−ラ ロシュ アーゲー 優れたシャペロン活性およびフォールディング活性を有するキメラ融合タンパク質
ATE529436T1 (de) 2007-04-20 2011-11-15 Hoffmann La Roche Erkennung von primären infektionen mit krankheitserregern
CA2705716C (en) 2007-12-13 2013-03-19 F. Hoffmann-La Roche Ag Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies
EP2127678A1 (en) * 2008-05-26 2009-12-02 Roche Diagnostics GmbH SlpA as a tool for recombinant protein and enzyme technology

Similar Documents

Publication Publication Date Title
JP2015529211A5 (enExample)
JP2016511417A5 (enExample)
MX2015012823A (es) Ensayo de combinacion de antigeno-anticuerpo del virus de la hepatitis c (vhc) y metodos y composiciones para usarlo.
SG10201906750XA (en) Assays for detecting the presence or amount of an anti-drug antibody
ZA202002415B (en) Detection of symmetrical dimethylarginine
JO3812B1 (ar) أجسام مضادة ترتبط بالمركب الترابطي البشري للموت المبرمج 1 (pd-l1)
JP2009284902A5 (enExample)
BR112015022844A2 (pt) métodos para detecção de anticorpos para doadores específicos e sistemas para pratica destes
MX2017011489A (es) Detección de moléculas pequeñas mediante nanoporos a través de ensayos de competición.
Ngubane et al. High-throughput sequencing enhanced phage display identifies peptides that bind mycobacteria
BR112015023355A8 (pt) antígenos recombinantes ns3 de hcv e mutantes dos mesmos para detecção de anticorpos aprimorada.
JP2017536846A5 (enExample)
MX353464B (es) Antigenos tpn47 de treponema pallidum, inmunoreactivos, solubles.
JP2016528486A5 (enExample)
JP2013174612A5 (enExample)
Kim et al. Dual synergistic response for the electrochemical detection of H1N1 virus and viral proteins using high affinity peptide receptors
WO2018068064A3 (en) Mycobacterium tuberculosis proteins in diagnostic assays and devices for tuberculosis detection and diagnosis
JP2014524583A5 (enExample)
Kim et al. A one-step immunoassay based on switching peptides for diagnosis of porcine epidemic diarrhea virus (PEDV) using screened Fv-antibodies
WO2015128394A3 (en) Soluble and immunoreactive variants of htlv capsid antigen p24
JP2017512200A5 (enExample)
WO2004076684A3 (en) Compositions and methods for the detection of mammalian muscle troponin i
WO2016069762A3 (en) Subject anti-hcv antibody detection assays employing ns3 capture peptides
JP2017037014A5 (enExample)
JP2013186124A5 (enExample)